This result is consistent with others who have reported increased Chrm2 expression in HF rats treated with carvedilol (an α- and β-blocker), indicating that the upregulation of muscarinic receptors is consistent with cardioprotection [124]. Here, CHRM2 is linked to hydrops fetalis.